Procter & Gamble has agreed to acquire the premium supplements brand Thorne for $3.8 billion, a move that significantly expands the consumer-goods giant’s footprint in the fast-growing health and wellness market.
The acquisition marks one of P&G’s most substantial bets on the personal-health category, an area the company has increasingly targeted as demand for vitamins, minerals and dietary supplements continues to climb among health-conscious consumers.
“This is a play to grow our health business,” P&G Chief Executive Shailesh Jejurikar said in an interview, framing Thorne as a strategic addition that complements the company’s existing portfolio of personal-care and healthcare brands.
Founded as a specialist in high-quality nutritional supplements, Thorne has built a reputation among athletes, medical practitioners and wellness enthusiasts for its science-backed formulations. The brand also operates a direct-to-consumer model and offers at-home health testing, positioning it at the intersection of supplements and personalized wellness.
The deal comes as P&G, the maker of household names including Tide, Pampers and Gillette, looks to diversify its revenue streams beyond its traditional cleaning and grooming categories. Health-related products typically command higher margins and benefit from recurring consumer demand.
The transaction also arrives during a period of pressure on the company’s core operations. P&G has navigated headwinds from softer consumer demand and rising costs, having earlier flagged a potential $1 billion tariff impact for 2026. Expanding into higher-growth wellness segments offers a path to offset some of those challenges.
The global supplements market has expanded rapidly in recent years, driven by aging populations, growing interest in preventive health and the rise of personalized nutrition. Major consumer and pharmaceutical companies have moved aggressively to capture share of the category.
P&G has signaled that health will be a central pillar of its long-term growth strategy, and the Thorne acquisition provides an established premium brand with an existing customer base and research capabilities.
The deal is expected to close subject to customary regulatory approvals. While specific integration details are still emerging, the acquisition underscores P&G’s intent to compete more directly in the wellness economy as it seeks new avenues for growth.